Accepted for/Published in: JMIR Research Protocols
Date Submitted: Oct 18, 2022
Open Peer Review Period: Oct 18, 2022 - Dec 13, 2022
Date Accepted: Dec 22, 2022
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
A study protocol for evaluating the effectiveness of a whole-system intervention (Join Us: Move Play, JUMP) implemented at the neighbourhood level, to increase childrens (age 5-11 years) accelerometer measured physical activity: a quasi-experimental trial
ABSTRACT
Background:
Daily physical activity is vital for the health and development of children. However, many children are inactive. Previous attempts to achieve sustained increases in daily physical activity in children have been ineffective. Join Us: Move Play (JU:MP) is a whole system, complex community-based intervention aiming to increase physical activity levels of children, aged 5-14 years, living in areas of Bradford, England, which are multi-cultural and have high deprivation.
Objective:
The purpose of this quasi-experimental control trial is to assess whether the JU:MP programme increases primary school children’s physical activity.
Methods:
The study design is a two-armed quasi-experimental non-blinded non-equivalent groups design study, conducted with primary school aged children (5-11years) at three time-points including baseline [before intervention], 24 months [during intervention], and 36 months [post intervention]. Children attending primary schools within the intervention area will be invited to participate. Children attending similar schools, within similar neighbourhoods based upon school and community census demographics (deprivation, free school meals, ethnicity) outside of the JU:MP geographical area will be invited to participate within the control condition. At each time point, consenting participants will wear an accelerometer for 7 days, 24 hours a day to measure the primary outcome – average daily moderate-to-vigorous physical activity. Multivariable mixed effects linear regression will be applied to estimate differences in the primary outcome between the two arms at 24 months, and 36 months, on an Intention-to-Treat basis; and also the secondary outcome analysis, which will explore changes in socio-emotional well-being (teacher reported), quality of life (parental/carer reported) and other contextual factors (parents/carer reported); segments of the day activity, sleep, sedentary screen, frequency of places to be active, parent practices (non-directive support and autonomy support), social cohesion neighbourhood walking/exercise environment.
Results:
Recruitment occurred from July 2021 to March 2022, and baseline data collection from September 2021 to March 2022. As of March 2022 (end of baseline data collection) a total of 1454 children from 37 schools (17 intervention, 20 control schools) have been recruited. Follow-up data collections will occur first during September 2023 to March 2024, and the second and final follow-up data collection will occur during September 2024 to March 2025. Data analysis has not begun and final results to be published December 2025.
Conclusions:
This article describes the protocol for a quasi-experimental controlled trial examining a novel whole-systems intervention. Clinical Trial: ISRCTN; ISRCTN14332797, https://www.isrctn.com/ISRCTN14332797
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.